Laboratory Investigation

TABLE 2

FROM:

Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration

Bo Jin, Harvey J Alter, Zhi-Cheng Zhang, J Wai-Kuo Shih, Juan M Esteban, Tao Sun, Yun-Sheng Yang, Qi Qiu, Xiao-Lin Liu, Lin Yao, Hai-Dong Wang and Liu-Fang Cheng

BACK TO ARTICLE

Table 2. Hepatic and renal function test (meanplusminuss.d.)

Group I (n=4) II (n=4) III (n=4) IV (n=3) F-value P-value
ALT (IU/l)38.25plusminus9.1135.25plusminus6.1834.00plusminus11.7540.67plusminus16.010.270.8473
AST (IU/l)45.25plusminus6.2957.25plusminus11.8754.50plusminus15.8443.67plusminus26.030.690.5785
Bilirubin (mumol/l)0.62plusminus0.531.08plusminus0.680.43plusminus0.220.40plusminus0.201.650.2354
Total serum protein (g/l)67.00plusminus10.3660.00plusminus6.4865.50plusminus9.9864.33plusminus14.010.350.7901
Urea (mmol/l)7.10plusminus0.638.33plusminus1.377.40plusminus1.239.77plusminus5.360.770.5343
Creatinine (mumol/l)136.75plusminus15.2093.25plusminus16.82131.50plusminus36.32153.67plusminus50.142.490.1145

 Note: Blood samples of group II were taken at week 13 and groups I, III, and IV at week 25.

BACK TO ARTICLE